2) Biological Warfare Defense Therapeutics
Abstract
Therapeutics represent an important component of integrated layered defense. Therapeutics will mitigate the impact of biological threats to the warfighter by enabling rapid recovery and expediting return to the fight. This effort funds biomedical research focused on the early discovery and evaluation of therapeutic countermeasures against known and emerging biological warfare (BW) threats for which Food & Drug Administration (FDA)-approved therapeutics are limited or lacking. Effort supports transition of lead candidates from MT2 for further development before transitioning to advanced development.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2025
- Source ID
- 59b584d78c3f28cc2af8c646f0887d62